Ipsen: Parvus AM Europe Ltd exceeds 5% of voting rights
The declarant stated that it held, on behalf of the said clients and funds, 6,625,782 Ipsen shares representing the same number of voting rights, i.e. 7.91% of the capital and 5.02% of the voting rights of the French pharmaceutical company.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction